Imexpharm Corp (IMP) — Cash Flow Quality Index
Latest as of June 2026:
0.59x
Imexpharm Corp (IMP) has a Cash Flow Quality Index of 0.59x as of June 2026. Operating cash flow of ₫55.75 Billion is below net income of ₫93.93 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Imexpharm Corp cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
0.59x
Operating CF / Net Income
Operating Cash Flow
₫55.75 Billion
VND
Net Income
₫93.93 Billion
VND
Data as of
Jun 2026
Most recent filing
Imexpharm Corp Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Imexpharm Corp across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Imexpharm Corp.
Annual Cash Flow Quality Index for Imexpharm Corp (2019–2025)
Year-by-year earnings quality comparison for Imexpharm Corp.
| Year | Quality Index | Operating CF (VND) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | ₫54.17 Billion | ₫349.14 Billion | ▼ -77.0% |
| 2024 | 0.67x | ₫216.27 Billion | ₫320.86 Billion | ▲ +598.9% |
| 2023 | -0.14x | ₫-40.47 Billion | ₫299.56 Billion | ▼ -108.3% |
| 2022 | 1.62x | ₫378.60 Billion | ₫233.96 Billion | ▲ +30.3% |
| 2021 | 1.24x | ₫234.88 Billion | ₫189.09 Billion | ▲ +256.1% |
| 2020 | 0.35x | ₫73.15 Billion | ₫209.70 Billion | ▼ -14.9% |
| 2019 | 0.41x | ₫66.59 Billion | ₫162.39 Billion | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.